- Home
- VRA vs INBX Comparison
VRA vs INBX Comparison
Compare VRA & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- INBX
- Stock Information
- Founded
- VRA 1982
- INBX 2010
- Country
- VRA United States
- INBX United States
- Employees
- VRA N/A
- INBX N/A
- Industry
- VRA Apparel
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- VRA Consumer Discretionary
- INBX Health Care
- Exchange
- VRA Nasdaq
- INBX Nasdaq
- Market Cap
- VRA 102.9M
- INBX 218.9M
- IPO Year
- VRA 2010
- INBX 2020
- Fundamental
- Price
- VRA $3.72
- INBX $12.74
- Analyst Decision
- VRA Strong Buy
- INBX Hold
- Analyst Count
- VRA 1
- INBX 1
- Target Price
- VRA $5.50
- INBX N/A
- AVG Volume (30 Days)
- VRA 363.1K
- INBX 74.4K
- Earning Date
- VRA 12-11-2024
- INBX 11-14-2024
- Dividend Yield
- VRA N/A
- INBX N/A
- EPS Growth
- VRA N/A
- INBX N/A
- EPS
- VRA N/A
- INBX 119.38
- Revenue
- VRA $405,268,000.00
- INBX $1,568,000.00
- Revenue This Year
- VRA N/A
- INBX N/A
- Revenue Next Year
- VRA $4.90
- INBX N/A
- P/E Ratio
- VRA N/A
- INBX $0.11
- Revenue Growth
- VRA N/A
- INBX 19.24
- 52 Week Low
- VRA $3.27
- INBX $10.80
- 52 Week High
- VRA $8.32
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- VRA 40.52
- INBX 32.23
- Support Level
- VRA $3.46
- INBX $13.57
- Resistance Level
- VRA $3.97
- INBX $16.83
- Average True Range (ATR)
- VRA 0.22
- INBX 0.94
- MACD
- VRA 0.05
- INBX -0.21
- Stochastic Oscillator
- VRA 54.88
- INBX 1.68
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.